Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma.

about

Evaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma.

Item

http://www.wikidata.org/entity/Q51180085

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Evaluation of the Expression o ...... 2 (HER2) in Gastric Carcinoma.

@en

Evaluation of the Expression of the Human Epithelial Receptor 2

@nl

type

Item

label

Evaluation of the Expression o ...... 2 (HER2) in Gastric Carcinoma.

@en

Evaluation of the Expression of the Human Epithelial Receptor 2

@nl

prefLabel

Evaluation of the Expression o ...... 2 (HER2) in Gastric Carcinoma.

@en

Evaluation of the Expression of the Human Epithelial Receptor 2

@nl

P1476

Evaluation of the Expression o ...... 2 (HER2) in Gastric Carcinoma

@en

P2093

Daniel Kenji Fukuhara

http://www.w3.org/2001/XMLSchema#string

Elias Jirjoss Ilias

http://www.w3.org/2001/XMLSchema#string

Fábio Rodrigues Thuler

http://www.w3.org/2001/XMLSchema#string

Laura Carolina Lopez Claro

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.

Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.

Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.

HER2 expression in gastric and oesophageal cancer: a meta-analytic review

Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization.

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

P304

7951365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/7951365

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Alberto Malheiros

Roberto de Moraes Cordts Filho

Paulo Kassab

Mabel Tatty de Medeiros Fracassi

Patrícia Colombo-Souza

Wilson Rodrigues de Freitas Junior

P577

2016-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105465

http://www.w3.org/2001/XMLSchema#string

P932

5220523

http://www.w3.org/2001/XMLSchema#string